Michael Burdiek was named Chair of the Board of DocGo Inc. As of November 6, 2026, DocGo Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on April 22, 2026, naming 1 appointment (Form 8-K, April 22, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like DocGo Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
DocGo Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-04-22. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as DocGo Inc. files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-04-22 | In | Chair of the Board | 8-K, 2026-04-22 |
Selling to them or working with them? See who runs DocGo Inc. now and the warning signs.
Free to see. No signup.
Watch DocGo Inc.
Get an email when DocGo Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on DocGo Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on DocGo Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DocGo Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Who leads DocGo Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chair of the Board: Michael Burdiek, appointed (filed 2026-04-22).
New leaders reset buying decisions — get the Full Report on DocGo Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chair of the Board at DocGo Inc., with the record behind each one.
Find candidates like Chair of the Board at DocGo Inc.Every change, in the filing's words
Appointed: Michael Burdiek, Chair of the Board
In connection with Dr. Klasko's notice of departure from the Board and his Board and committee positions, the Board's Nominating and Corporate Governance Committee and the Board reassessed the leadership of the Board and appointed Michael Burdiek, a long-serving independent member of the Board, as an independent Chair of the Board, effective as of the Effective Time, with such duties and responsibilities as are customary to the office of Chair of the Board and to be assigned by the Board from time to time.
- On April 17, 2026, Stephen K. Klasko, MD notified DocGo Inc. (the "Company") of his decision to step down as a member of the Board of Directors (the "Board") and his other Board and committee positions because he accepted a new significant healthcare leadership role, effective as of the conclusion of the Company's 2026 Annual Meeting of Stockholders expected to be held on June 16, 2026 (the "Effective Time").
- Dr. Klasko's decision to step down from the Board was not the result of any disagreement with the Company on any matter relating to the Company's operations, disclosures, policies or practices.
- The Company is sincerely grateful to Dr. Klasko for his dedicated service on the Board and his contributions to the Company since joining the Board in October 2024.
- Mr. Burdiek will hold such position until his successor shall have been duly elected and qualified or his earlier resignation, disqualification, death or removal.
Tools for this story
Each opens in a new tab, filled in for DocGo Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.